Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.

Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hägglund H, Mattsson J, Uhlin M.

Cent Eur J Immunol. 2019;44(1):84-91. doi: 10.5114/ceji.2018.75831. Epub 2019 Apr 15.

2.

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.

Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, David Fuchs, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR; Study Group of the European Competence Network on Mastocytosis (ECNM).

J Allergy Clin Immunol Pract. 2019 Jan;7(1):81-87. doi: 10.1016/j.jaip.2018.09.024. Epub 2018 Nov 8. Review.

PMID:
30416055
3.

[Cutaneous mastocytosis - update and clinical guidelines].

Bergström A, Rollman O, Emtestam L, Mattson M, Hägglund H, Nilsson G, Karlsson M.

Lakartidningen. 2018 Oct 22;115. pii: FASY. Review. Swedish.

4.

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.

Pahnke S, Egeland T, Halter J, Hägglund H, Shaw BE, Woolfrey AE, Szer J; Working Group Medical of the World Marrow Donor Association.

Bone Marrow Transplant. 2019 Jun;54(6):858-866. doi: 10.1038/s41409-018-0350-y. Epub 2018 Oct 3.

PMID:
30283148
5.

Effects of sauna bath on heart failure: A systematic review and meta-analysis.

Källström M, Soveri I, Oldgren J, Laukkanen J, Ichiki T, Tei C, Timmerman M, Berglund L, Hägglund H.

Clin Cardiol. 2018 Nov;41(11):1491-1501. doi: 10.1002/clc.23077. Epub 2018 Nov 21.

6.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H.

Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2.

7.

Autologous haematopoietic stem cell transplantation for neurological diseases.

Burman J, Tolf A, Hägglund H, Askmark H.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):147-155. doi: 10.1136/jnnp-2017-316271. Epub 2017 Sep 2. Review.

8.

Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.

Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H.

J Clin Apher. 2018 Jun;33(3):226-235. doi: 10.1002/jca.21576. Epub 2017 Aug 18.

PMID:
28833474
9.

Cardiorespiratory fitness and health-related quality of life in women at risk for gestational diabetes.

Engberg E, Tikkanen HO, Koponen A, Hägglund H, Kukkonen-Harjula K, Tiitinen A, Peltonen JE, Pöyhönen-Alho M.

Scand J Med Sci Sports. 2018 Jan;28(1):203-211. doi: 10.1111/sms.12896. Epub 2017 May 12.

PMID:
28415143
10.

Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.

Ajeganova S, Tesfa D, Hägglund H, Fadeel B, Vedin I, Zignego AL, Palmblad J.

Arthritis Res Ther. 2017 Mar 7;19(1):44. doi: 10.1186/s13075-017-1241-0.

11.

G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield.

Machaczka M, Hägglund H, Staver E, Joks M, Hassan M, Wahlin BE, Axdorph Nygell U.

J Clin Apher. 2017 Dec;32(6):384-391. doi: 10.1002/jca.21524. Epub 2017 Jan 19.

PMID:
28101890
12.

Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis.

Lyberg K, Ali HA, Grootens J, Kjellander M, Tirfing M, Arock M, Hägglund H, Nilsson G, Ungerstedt J.

Oncotarget. 2017 Feb 7;8(6):9647-9659. doi: 10.18632/oncotarget.14181.

13.

Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report.

Håkansson I, Sandstedt A, Lundin F, Askmark H, Pirskanen R, Carlson K, Piehl F, Hägglund H.

Neuromuscul Disord. 2017 Jan;27(1):90-93. doi: 10.1016/j.nmd.2016.09.020. Epub 2016 Sep 28.

PMID:
27863874
14.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2016 Jun;5(6):845. doi: 10.5966/sctm.2015-0021erratum. No abstract available.

15.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J, Perales MA, George T, Shore T, Sperr W, Saber W, Kota V, Yavuz AS, Pullarkat V, Rogosheske J, Hogan W, Van Besien K, Hagglund H, Damaj G, Arock M, Horny HP, Metcalfe DD, Deeg HJ, Devine S, Weisdorf D, Akin C, Valent P.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1348-1356. doi: 10.1016/j.bbmt.2016.04.018. Epub 2016 Apr 27. No abstract available.

16.

Detection of circulating mast cells in advanced systemic mastocytosis.

Dahlin JS, Ungerstedt JS, Grootens J, Sander B, Gülen T, Hägglund H, Nilsson G.

Leukemia. 2016 Sep;30(9):1953-6. doi: 10.1038/leu.2016.105. Epub 2016 Apr 27. No abstract available.

PMID:
27118407
17.

Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome.

Rissanen AP, Koskela-Koivisto T, Hägglund H, Koponen AS, Aho JM, Pöyhönen-Alho M, Tiitinen A, Tikkanen HO, Peltonen JE.

Physiol Rep. 2016 Feb;4(4). pii: e12719. doi: 10.14814/phy2.12719.

18.

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.

Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H.

Acta Derm Venereol. 2016 Jun 15;96(5):602-12. doi: 10.2340/00015555-2325.

19.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JNG, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P.

J Allergy Clin Immunol. 2016 Jan;137(1):35-45. doi: 10.1016/j.jaci.2015.08.034. Epub 2015 Oct 21. Review.

PMID:
26476479
20.

Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.

Gülen T, Hägglund H, Dahlén B, Nilsson G.

J Intern Med. 2016 Mar;279(3):211-28. doi: 10.1111/joim.12410. Epub 2015 Sep 8. Review.

21.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2015 Oct;4(10):1199-213. doi: 10.5966/sctm.2015-0021. Epub 2015 Aug 18. Erratum in: Stem Cells Transl Med. 2016 Jun;5(6):845.

22.

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

Worel N, Buser A, Greinix HT, Hägglund H, Navarro W, Pulsipher MA, Nicoloso de Faveri G, Bengtsson M, Billen A, Espino G, Fechter M, Giudice V, Hölig K, Kanamori H, Kodera Y, Leitner G, Netelenbos T, Niederwieser D, van Walraven SM, Rocha V, Torosian T, Vergueiro C, Weisdorf D, Yabe H, Halter JP.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2052-2060. doi: 10.1016/j.bbmt.2015.08.009. Epub 2015 Aug 10.

23.

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.

Bergfelt E, Kozlowski P, Ahlberg L, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Åström M, Amini RM, Hallböök H.

Med Oncol. 2015 Apr;32(4):135. doi: 10.1007/s12032-015-0582-2. Epub 2015 Mar 22.

PMID:
25796502
24.

Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation.

Hägglund H, Remberger M, Ringden O.

Bone Marrow Transplant. 2014 Dec;49(12):1541-2. doi: 10.1038/bmt.2014.184. Epub 2014 Sep 22. No abstract available.

PMID:
25243627
25.

Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3.

Machaczka M, Kämpe Björkvall C, Wieremiejczyk J, Paucar Arce M, Myhr-Eriksson K, Klimkowska M, Hägglund H, Svenningsson P.

Arch Immunol Ther Exp (Warsz). 2015 Feb;63(1):65-71. doi: 10.1007/s00005-014-0308-8. Epub 2014 Sep 10.

26.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

Ustun C, Reiter A, Scott BL, Nakamura R, Damaj G, Kreil S, Shanley R, Hogan WJ, Perales MA, Shore T, Baurmann H, Stuart R, Gruhn B, Doubek M, Hsu JW, Tholouli E, Gromke T, Godley LA, Pagano L, Gilman A, Wagner EM, Shwayder T, Bornhäuser M, Papadopoulos EB, Böhm A, Vercellotti G, Van Lint MT, Schmid C, Rabitsch W, Pullarkat V, Legrand F, Yakoub-Agha I, Saber W, Barrett J, Hermine O, Hagglund H, Sperr WR, Popat U, Alyea EP, Devine S, Deeg HJ, Weisdorf D, Akin C, Valent P.

J Clin Oncol. 2014 Oct 10;32(29):3264-74. doi: 10.1200/JCO.2014.55.2018. Epub 2014 Aug 25.

27.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.

Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.

Mult Scler. 2015 Feb;21(2):189-97. doi: 10.1177/1352458514541978. Epub 2014 Jul 30.

PMID:
25078274
28.

The presence of mast cell clonality in patients with unexplained anaphylaxis.

Gülen T, Hägglund H, Sander B, Dahlén B, Nilsson G.

Clin Exp Allergy. 2014 Sep;44(9):1179-87. doi: 10.1111/cea.12369.

PMID:
25039926
29.

Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.

Hägglund H, Sander B, Ahmadi A, Gülen T, Nilsson G.

Med Oncol. 2014 Aug;31(8):123. doi: 10.1007/s12032-014-0123-4. Epub 2014 Jul 18.

PMID:
25034364
30.

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study.

Hulegårdh E, Hägglund H, Ahlberg L, Karlsson K, Karbach H, Markuszewska A, Persson I, Åström M, Hallböök H.

Med Oncol. 2014 Aug;31(8):66. doi: 10.1007/s12032-014-0066-9. Epub 2014 Jun 26.

PMID:
24965535
31.

Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.

Gülen T, Hägglund H, Dahlén SE, Sander B, Dahlén B, Nilsson G.

Lancet. 2014 May 3;383(9928):1608. doi: 10.1016/S0140-6736(14)60585-7. No abstract available.

PMID:
24792857
32.

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Valent P, Sotlar K, Sperr WR, Escribano L, Yavuz S, Reiter A, George TI, Kluin-Nelemans HC, Hermine O, Butterfield JH, Hägglund H, Ustun C, Hornick JL, Triggiani M, Radia D, Akin C, Hartmann K, Gotlib J, Schwartz LB, Verstovsek S, Orfao A, Metcalfe DD, Arock M, Horny HP.

Ann Oncol. 2014 Sep;25(9):1691-700. doi: 10.1093/annonc/mdu047. Epub 2014 Mar 27. Review.

33.

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19.

PMID:
24554104
34.

Increased risk of malignant melanoma in patients with systemic mastocytosis?

Hägglund H, Sander B, Gülen T, Lindelöf B, Nilsson G.

Acta Derm Venereol. 2014 Sep;94(5):583-4. doi: 10.2340/00015555-1788. No abstract available.

35.

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.

Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Amini RM, Hallböök H; Swedish Adult ALL Group.

Eur J Haematol. 2014;92(5):377-81. doi: 10.1111/ejh.12269. Epub 2014 Feb 21.

PMID:
24443846
36.

Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.

Press R, Askmark H, Svenningsson A, Andersen O, Axelson HW, Strömberg U, Wahlin A, Isaksson C, Johansson JE, Hägglund H.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):618-24. doi: 10.1136/jnnp-2013-306014. Epub 2013 Nov 21.

PMID:
24262917
37.

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.

Machaczka M, Johansson JE, Remberger M, Hallböök H, Lazarevic VLj, Wahlin BE, Omar H, Wahlin A, Juliusson G, Kimby E, Hägglund H.

Med Oncol. 2013 Dec;30(4):762. doi: 10.1007/s12032-013-0762-x. Epub 2013 Nov 9.

PMID:
24214180
38.

High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.

Gülen T, Hägglund H, Dahlén B, Nilsson G.

Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.

PMID:
24164252
39.

Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.

Ruutu T, Juvonen E, Remberger M, Remes K, Volin L, Mattsson J, Nihtinen A, Hägglund H, Ringdén O; Nordic Group for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2014 Jan;20(1):135-8. doi: 10.1016/j.bbmt.2013.10.014. Epub 2013 Oct 17.

40.

The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.

Gülen T, Dahlén B, Sander B, Hägglund H, Nilsson G.

Clin Transl Allergy. 2013 Jul 4;3(1):22. doi: 10.1186/2045-7022-3-22.

41.

Alveolar gas exchange, oxygen delivery and tissue deoxygenation in men and women during incremental exercise.

Peltonen JE, Hägglund H, Koskela-Koivisto T, Koponen AS, Aho JM, Rissanen AP, Shoemaker JK, Tiitinen A, Tikkanen HO.

Respir Physiol Neurobiol. 2013 Aug 15;188(2):102-12. doi: 10.1016/j.resp.2013.05.014. Epub 2013 May 24.

PMID:
23707876
42.

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors.

Remberger M, Ringdén O, Hägglund H, Svahn BM, Ljungman P, Uhlin M, Mattsson J.

Clin Transplant. 2013 Jul-Aug;27(4):E368-74. doi: 10.1111/ctr.12131. Epub 2013 May 22.

PMID:
23701240
43.

Bone marrow derived cells in adult skeletal muscle tissue in humans.

Strömberg A, Jansson M, Fischer H, Rullman E, Hägglund H, Gustafsson T.

Skelet Muscle. 2013 May 16;3(1):12. doi: 10.1186/2044-5040-3-12.

44.

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.

Ringdén O, Erkers T, Aschan J, Garming-Legert K, Le Blanc K, Hägglund H, Omazic B, Svenberg P, Dahllöf G, Mattsson J, Ljungman P, Remberger M.

J Intern Med. 2013 Aug;274(2):153-62. doi: 10.1111/joim.12056. Epub 2013 Mar 25.

45.

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.

Valent P, Arock M, Bonadonna P, Brockow K, Broesby-Olsen S, Escribano L, Gleixner KV, Grattan C, Hadzijusufovic E, Hägglund H, Hermine O, Horny HP, Kluin-Nelemans HC, Maurer M, Niedoszytko M, Nedoszytko B, Nilsson G, Oude-Elberink HN, Orfao A, Radia D, Reiter A, Siebenhaar F, Sotlar K, Sperr WR, Triggiani M, VanDoormaal JJ, Várkonyi J, Yavuz S, Hartmann K.

Wien Klin Wochenschr. 2012 Dec;124(23-24):807-14. doi: 10.1007/s00508-012-0293-z. Epub 2012 Nov 20. Review.

PMID:
23179435
46.

Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation.

Westerberg CM, Hägglund H, Nilsson G.

Cell Death Dis. 2012 Nov 15;3:e417. doi: 10.1038/cddis.2012.157.

47.

Low total haemoglobin mass, blood volume and aerobic capacity in men with type 1 diabetes.

Koponen AS, Peltonen JE, Päivinen MK, Aho JM, Hägglund HJ, Uusitalo AL, Lindholm HJ, Tikkanen HO.

Eur J Appl Physiol. 2013 May;113(5):1181-8. doi: 10.1007/s00421-012-2532-4. Epub 2012 Nov 6.

PMID:
23129089
48.

Cardiovascular autonomic nervous system function and aerobic capacity in type 1 diabetes.

Hägglund H, Uusitalo A, Peltonen JE, Koponen AS, Aho J, Tiinanen S, Seppänen T, Tulppo M, Tikkanen HO.

Front Physiol. 2012 Sep 7;3:356. doi: 10.3389/fphys.2012.00356. eCollection 2012.

49.

Alveolar gas exchange and tissue oxygenation during incremental treadmill exercise, and their associations with blood O(2) carrying capacity.

Rissanen AP, Tikkanen HO, Koponen AS, Aho JM, Hägglund H, Lindholm H, Peltonen JE.

Front Physiol. 2012 Jul 11;3:265. doi: 10.3389/fphys.2012.00265. eCollection 2012.

50.

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A, Szer J, Aljurf MD, Weisdorf D, Horowitz MM, Greinix H, Niederwieser D, Gratwohl A, Kodera Y, Confer D.

Bone Marrow Transplant. 2013 Feb;48(2):220-5. doi: 10.1038/bmt.2012.119. Epub 2012 Jul 9.

PMID:
22773129

Supplemental Content

Loading ...
Support Center